Stocks
ImmunoGen (IMGN) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.70 | 2.27 | 13.7 | 1.19 | 1.19 | -9.41 | |||
| Changes by years, y/y, % | -53% | +34% | +503% | -91% | 0% | -19.9% | |||
ImmunoGen. Debt/EBITDA
ImmunoGen. Debt/EBITDA, changes, %
ImmunoGen (IMGN) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q2 | 2023Q4 | 2024Q1 | 2023Q3 | LTM ? | |||
| Debt/EBITDA | 3.70 | 35.4 | 35.4 | -9.41 | -9.41 | -9.41 | ||
| Changes by years, y/y, % | +147% | +1 750% | +2 876% | -826% | -729% | |||
| Changes by quarters, q/q, % | +185% | +859% | 0% | -127% | 0% | |||
